Dynamis Pharmaceuticals, Inc. — Form D/A
Dynamis Pharmaceuticals, Inc. of JENKINTOWN, PA, a company, filed a Form D amendment with the SEC on 2018-04-25. $489K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-04-25
- Form: D/A
- Accession: 0001708606-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $489K
- Minimum investment: $3K
- Investors: 15
- Date of first sale: 2017-06-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-289125
Issuer
- Name: Dynamis Pharmaceuticals, Inc.
- CIK: 0001708606
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 261 OLD YORK ROAD, JENKINTOWN, PA, 19046
- Phone: 2153765290
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| David Smith | Director | Saint Louis, MO |
| David Smith | Executive Officer | Saint Louis, MO |
| Annette Tobia | Director | Jenkintown, PA |
| Annette Tobia | Executive Officer | Jenkintown, PA |
Other filings by this issuer (3)
More